Purchase Order HHSN272201400660P
Award Date
6/26/14
Potential Completion Date
7/26/14
Potential Value
$3.9K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $164,700.00 firm fixed-price purchase order is for monoclonal antibodies and plasmids services, with a completion date of June 14, 2026. The contract does not have a set-aside designation. Genscript is a key supplier of...
This federal contract award is for a CUSTOMIZED POLYCLONAL ANTIBODY GENERATION SERVICE provided by Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $14,932.80, was awarded on August 21, 2015 by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Genscript has...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $3,800.00, is for custom monoclonal antibody production services to support NIAID's biomedical research and public health initiatives. This contract does not have a set-aside designation. Genscript...
This firm fixed-price purchase order, valued at $16,215, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's biomedical research and public health initiatives. Genscript, a for-profit organization, has received numerous prime...
This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
This federal contract award, valued at $10,420.74, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom gene synthesis services to support biomedical research and public health initiatives. Genscript USA Inc. is a prime contractor that has received numerous awards from HHS...
This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....
The federal contract HHSN272201600094P was awarded to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $4,035.50 Firm Fixed Price contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract does not have a set-aside designation. Under this contract, Genscript is providing a wide range of molecular...
This federal contract award, valued at $13,587.57, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for the provision of a customized protein service in a bacterial expression system, involving the production of 3 mg of protein for 6 different proteins. This purchase order contract has a firm fixed price pricing type and does not utilize any set-aside designations. Genscript...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $18,820.52, is for the production of customized DNA and monoclonal antibodies. The contract does not have a set-aside designation. Genscript USA Inc. is a for-profit organization that specializes in advanced...